NĒRx BioSciences
2 known investors
NĒRx Biosciences is a pre-clinical stage biotechnology company developing targeted anticancer therapeutics focused on the DNA damage response (DDR) and DNA repair. Its approach targets the proteins that detect DNA damage (DDR sensors) rather than the kinases that react to them, aiming to improve patient response and survival.